V beta 17 T-cell receptor peptide vaccine. Results of a phase I dose-finding study in patients with rheumatoid arthritis.
Moreland
L W
LW
University of Alabama at Birmingham 068 Spain Rehabilitation Center 35294-0006, USA.
Heck
L W
LW
Koopman
W J
WJ
Saway
P A
PA
Adamson
T C
TC
Fronek
Z
Z
O'Connor
R D
RD
Morgan
E E
EE
Diveley
J P
JP
Chieffo
N M
NM
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D004306:Dose-Response Relationship, Immunologic; D015333:Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; D006801:Humans; D007167:Immunotherapy; D008213:Lymphocyte Activation; D010455:Peptides / Q000276:immunology; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000737:chemistry / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D014611:Vaccination
D010455:Peptides; D016693:Receptors, Antigen, T-Cell, alpha-beta